Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001641172-25-018199

EVP Operations acquired 2,500,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Plassche Douglas EVP Operations 2025-07-03 Option exercise +2,500,000 $0.03 $75,000 2,500,000 D
Derivatives
Plassche Douglas EVP Operations 2025-07-03 Option exercise · Stock Options (right to buy) −2,500,000 5,000,000 D
Loading xslF345X05/ownership.xml…